Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timed intermittent bolus versus continuous TAP ropivacaine after hepatobiliary surgery
ACTRN12618000111279Phase 4Not yet recruiting
- Sponsor
- Dr Emilia Reece
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Dr Emilia Reece. Primary endpoint: Pain score on cough. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12618000111279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000111279.